General ENT News

ENT

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Stevenson M et al. - Bosentan is likely to be a more cost-effective first-line therapy for patients with PAH FC III in the UK than no active intervention.


Today in Economics of Medicine...keeping you current

Willingness to Pay for Maternal Health Outcomes: Are Women Willing to Pay More than Men
Applied Health Economics and Health Policy, 03/01/10

The changing economy may mean a change in plans
Physicians Practice, 02/26/10

The interface between residential aged care and the emergency department: a systematic review
Age and Aging, 02/25/10

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address